BioArctic AB (OSTO:BIOA B) Other Gross PPE : kr91 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is BioArctic AB Other Gross PPE?

BioArctic AB's Other Gross PPE for the quarter that ended in Mar. 2025 was kr91 Mil.

BioArctic AB's quarterly Other Gross PPE declined from Sep. 2024 (kr99 Mil) to Dec. 2024 (kr72 Mil) but then increased from Dec. 2024 (kr72 Mil) to Mar. 2025 (kr91 Mil).

BioArctic AB's annual Other Gross PPE declined from Dec. 2022 (kr91 Mil) to Dec. 2023 (kr65 Mil) but then increased from Dec. 2023 (kr65 Mil) to Dec. 2024 (kr72 Mil).

BioArctic AB Other Gross PPE Historical Data

The historical data trend for BioArctic AB's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB Other Gross PPE Chart

BioArctic AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Gross PPE

Get a 7-Day Free Trial

70.89

38.12

91.40

64.70

72.47

BioArctic AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Gross PPE	Get a 7-Day Free Trial															38.62	98.12	99.09	72.47	90.75

BioArctic AB Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

BioArctic AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (OSTO:BIOA B) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

BRCTF:USA BIOABs:UK 0RV2:UK B9A:Germany

Address

Warfvinges vag 35, Stockholm, SWE, SE-112 51

Website

https://www.bioarctic.se

BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

BioArctic AB Headlines

No Headlines